Patents for A61P 17 - Drugs for dermatological disorders (106,455)
05/1996
05/14/1996US5516768 Uncompetitive inhibition of steroid and 5α-reductose
05/09/1996WO1996013603A1 INTERLEUKIN-1 β CONVERTING ENZYME LIKE APOPTOSIS PROTEASE-3 AND 4
05/09/1996WO1996013266A1 Boronic ester and acid compounds, synthesis and uses
05/09/1996WO1996013265A1 4-heterocyclic piperidines promote release of growth hormone
05/09/1996WO1996013247A1 Antiodor, antimicrobial and preservative compositions and methods of using same
05/09/1996WO1996013164A1 Polymeric wound healing accelerators
05/09/1996CA2203920A1 Antiodor, antimicrobial and preservative compositions and methods of using same
05/09/1996CA2202784A1 4-heterocyclic piperidines promote release of growth hormone
05/08/1996EP0710478A1 Composition for topical application containing a lipase and an active agent precursor
05/08/1996EP0710239A1 Novel 9-n-bicyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines
05/08/1996EP0710227A1 Vitamin d analogues
05/08/1996EP0710111A1 Hormonal agent for the treatment of acne and its use
05/07/1996US5514712 Use of oils of chaulmoogra in the cosmetic and pharmaceutical domain, particularly in dermatology, for harmonizing pigmentation of the skin
05/07/1996US5514685 Antiinflammatory antoproliferative agents, immunosuppressants
05/07/1996US5514677 Hydroxamic acid based collagenase inhibitors
05/07/1996US5514661 Autoimmune disease treatment
05/07/1996US5514657 Wound healing, silver sulfadiazine, collagen
05/07/1996US5514654 N-acyldipeptides, processes for the preparation thereof and pharmaceutical compositions containing the same
05/07/1996US5514579 Human transglutaminases
05/07/1996US5514374 Cosmetic or pharmaceutical composition containing a black horehound extract
05/07/1996US5514370 High dosage topical forms of collagenase
05/07/1996CA1338310C Polycyclic peptide antibiotic and method for production thereof
05/02/1996WO1996012817A1 Combination method for acne treatment
05/02/1996WO1996012797A1 Production and use of human and plant methyltransferases
05/02/1996WO1996012742A1 Binding agents for treatment of inflammatory, autoimmune or allergic diseases
05/02/1996WO1996012741A1 Binding agents to cd23
05/02/1996WO1996012487A1 Combination method for acne treatment
05/02/1996CA2203364A1 Binding agents for treatment of inflammatory, autoimmune or allergic diseases
05/02/1996CA2203363A1 Binding agents to cd23
05/02/1996CA2203265A1 Production and use of human and plant methyltransferases
05/02/1996CA2199980A1 Combination method for acne treatment
05/02/1996CA2199979A1 Combination method for acne treatment
05/01/1996EP0709382A1 Aromatic dibenzofurane derivatives, pharmaceutical and cosmetic compositions containing them
05/01/1996EP0709092A2 Combinations of active ingredients for use against superinfections, containing wool wax acids and other fatty acids
05/01/1996EP0709091A2 Dermatologic compositions containing fatty acids and fatty acid glycerides against superinfections
05/01/1996EP0709089A2 Dermatologic compositions against superinfections containing ethoxylated and/or propoxylated alcohols and/or carboxylic acids
05/01/1996EP0709082A2 Combinations of active ingredients based on wool wax acids and glycerides of saturated fatty acids efficient against impure skin, slight forms of acne as well as propionibacterium acnes
05/01/1996EP0708776A1 Antiallergic imidazoazepines
05/01/1996EP0708768A1 Tri-substituted imidazoles having multiple therapeutic properties
05/01/1996EP0708755A1 Novel vitamin d analogues
05/01/1996EP0606386B1 Dermatological and/or cosmetological composition containing retinoids
05/01/1996CN1121715A 4-aryl-4-hydroxy-tetrahydropyrans and 3-aryl-3-hydroxy-tetrahydrofurans as 5-lipoxygenase inhibitors
05/01/1996CN1121427A Dongchuangling liniment for chilblain
04/1996
04/30/1996US5512683 Osteoporosis, immunosuppressant
04/30/1996US5512594 Administering to treat a medical condition mediated by one or more leukotrienes
04/30/1996US5512581 Antiinflammatory agent
04/30/1996US5512573 Skin irritation; prevention transplant rejection
04/30/1996US5512568 For treating a mammal having a disease state that is alleviated by treatment with an inosine 5'-monophosphate dehydrogenase inhibitor
04/30/1996US5512555 Administering a composition containing 5 alpha-reductase inhibitors and antiperspirant
04/30/1996CA2026278C Use of alkylphosphoric acid compounds for combatting psoriasis disorders
04/30/1996CA1338287C Hetrazepines and processes for preparing them
04/25/1996WO1996011950A1 Method of treating diabetes mellitus using kgf
04/25/1996WO1996011949A2 Analogs of keratinocyte growth factor
04/25/1996WO1996011933A1 Fused pyrrolocarbazoles
04/25/1996WO1996011685A2 Use of indole derivatives for the treatment of various diseases
04/24/1996EP0708111A1 17-Desoxy corticosteroid-21-esters, a process for their preparation and pharmaceutical compositions containing them
04/24/1996EP0707849A1 Use of derivatives of 2,4-bisubstituted phenols as 5-lipoxigenase inhibitors
04/24/1996EP0707566A1 Novel structural analogues of vitamin d
04/24/1996EP0707486A1 Cutaneous rejuvenating and healing product, method for its manufacture and uses thereof
04/24/1996CN1121074A Novel N-pyridyl carboxamides and derivatives, processes for their preparation and the pharmaceutical compositions which contain them
04/23/1996US5510496 Substituted pyrazolyl benzenesulfonamides
04/23/1996US5510391 Method of treating blood vessel disorders of the skin using vitamin K
04/23/1996US5510339 Method for the treatment of bronchial asthma by administration of topical anesthetics
04/23/1996US5510327 Containing tumor cytotoxic factor, basic amino acid or salt thereof, organic or inorganic salt
04/18/1996WO1996011274A1 Chimeric papillomavirus-like particles
04/18/1996WO1996011271A1 Novel ectoparasite saliva proteins and apparatus to collect such proteins
04/18/1996WO1996011200A1 Purine and guanine compounds as inhibitors of pnp
04/18/1996WO1996011192A1 Lta4 hydrolase inhibitors
04/18/1996WO1996011184A1 Colchicine derivatives and the therapeutical use thereof
04/18/1996WO1996010912A1 Method for reducing unwanted cellular adhesions
04/18/1996CA2202371A1 Lta4 hydrolase inhibitors
04/18/1996CA2201773A1 Purine and guanine compounds as inhibitors of pnp
04/17/1996EP0706797A2 Compositions containing carbohydrates obtained from plants of the family cactacea
04/17/1996EP0706795A2 Catechol diether compounds as inhibitors of TNF release
04/17/1996EP0706513A1 Fluoroalkoxy-substituted benzamides and their use as cyclic nucleotide phosphodiesterase inhibitors
04/17/1996EP0706509A1 Short chain 2-hydroxycarboxylic acid-based derivatives of ceramides
04/17/1996EP0706394A1 Method and composition for topical treatment of damaged tissue using histamine phosphate as active ingredient
04/17/1996EP0706370A1 Stable topical retinoid compositions
04/17/1996EP0706368A1 Anti-acne composition containing a poria cocos wolf extract
04/17/1996CN1031574C Process for preparation of 4-amino-delta-4, 6-steroid(s) compounds
04/16/1996US5508426 Antiarthritic agent
04/16/1996US5508300 Inhibit phosphodiesterase and production of tumor necrosis factor; treating inflammatory diseases
04/11/1996WO1996010634A1 Inhibitor of stem cell proliferation and uses thereof
04/11/1996WO1996010575A1 Biologically active silicon compounds and their therapeutic and cosmetic applications
04/11/1996WO1996010574A1 Method for preparing concentrated biologically active silicon compounds
04/11/1996WO1996010474A1 Razor cartridges comprising wound healing compositions
04/11/1996WO1996010416A1 DRUGS CONTAINING β-INTERFERON
04/11/1996WO1996005838A3 Combined preparation for the therapy of immune diseases
04/11/1996CA2199154A1 The use of medicaments containing interferon-beta
04/10/1996EP0705605A2 Use of fatty acid esters against superinfections
04/10/1996EP0705604A2 Dermatologic compositions containing a mixture of wool wax acids against superinfections
04/10/1996EP0705602A2 Use of alpha, omega-alcanoic dicarboxylic acids against superinfections
04/10/1996EP0705593A1 Dermatologic or cosmetic composition made up by an oil in water emulsion based on oily globules coated with a lamellar liquid crystal coating
04/10/1996EP0705261A1 Antiproliferative naphthyridines
04/10/1996EP0705102A1 Use of corrinoids in topical treatment of skin diseases
04/10/1996EP0512095B1 Methyl pyrrolidinone chitosan, production process and uses thereof
04/10/1996EP0504254B1 The use of gibberellins for the manufacture of a medicament for the treatment of prostatitis
04/10/1996EP0448697B1 Vitamin a analogues and their applications, in particular as cytotrophic and cytoprotective molecules, and pharmaceutical compositions containing same
04/10/1996CN1120339A New prednisolone derivates
04/10/1996CN1120039A Acylated aminoalknimidazoles and-triazoles